Drug recall · October 31, 2018
Amlodipine/Valsartan HCTZ 10 mg/320 mg/25 mg tablets recall
Why: CGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Amlodipine/Valsartan HCTZ 10 mg/320 mg/25 mg tablets, HDPE 90 cc bottles in cardboard trays Original NDC 13668-0325-30 Repackaged NDC 70518-1220-00
- Lots / codes
Lot # B0438903-052118 70518-1220-00
- Quantity
- 2 bottles of 90 tablets (180 tablets)
- Company
- RemedyRepack Inc., Indiana, PA
- Distribution
- Product was distributed to a medical facility in South Carolina
- Initiated
- August 24, 2018 · Voluntary: Firm initiated
- Classified
- October 24, 2018
- Reported
- October 31, 2018
- Ended
- October 29, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amlodipine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.